These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 37403948)
1. Bilateral Lacrimal Gland Mantle Cell Lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature. Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948 [TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features. Rasmussen PK Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159 [TBL] [Abstract][Full Text] [Related]
3. Mantle cell lymphoma in the ocular adnexal region. Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830 [TBL] [Abstract][Full Text] [Related]
4. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience. Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390 [TBL] [Abstract][Full Text] [Related]
7. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab]. Kanaji N; Ishibashi K; Uno H; Hino N Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485 [TBL] [Abstract][Full Text] [Related]
8. Mantle Cell Lymphoma of the Lacrimal Gland. Ana-Magadia MG; Takahashi Y; Valencia MRP; Kakizaki H J Craniofac Surg; 2019 Jan; 30(1):158-160. PubMed ID: 30339590 [TBL] [Abstract][Full Text] [Related]
9. Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission. Chakhachiro ZI; Saliba RM; Okoroji GJ; Korbling M; Alousi AM; Betul O; Anderlini P; Ciurea SO; Popat U; Champlin R; Samuels BI; Medeiros LJ; Bueso-Ramos C; Khouri IF Cancer; 2013 Sep; 119(18):3318-25. PubMed ID: 23775587 [TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort. Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219 [TBL] [Abstract][Full Text] [Related]
13. [Intraocular invasion of bilateral primary ocular adnexal mantle cell lymphoma: a case report]. Wei M; Chen H; Wang JH; Shuai J; Ji M Zhonghua Yan Ke Za Zhi; 2023 Jan; 59(1):52-56. PubMed ID: 36631059 [TBL] [Abstract][Full Text] [Related]
14. Results from the Belgian mantle cell lymphoma registry. Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652 [TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436 [TBL] [Abstract][Full Text] [Related]
16. [Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma]. Vorobyev VI; Gemdzhian EG; Dubrovin EI; Nesterova ES; Kaplanov KD; Volodicheva EM; Zherebtsova VA; Kravchenko SK Ter Arkh; 2019 Jul; 91(7):41-51. PubMed ID: 32598735 [TBL] [Abstract][Full Text] [Related]
17. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Hermine O; Hoster E; Walewski J; Bosly A; Stilgenbauer S; Thieblemont C; Szymczyk M; Bouabdallah R; Kneba M; Hallek M; Salles G; Feugier P; Ribrag V; Birkmann J; Forstpointner R; Haioun C; Hänel M; Casasnovas RO; Finke J; Peter N; Bouabdallah K; Sebban C; Fischer T; Dührsen U; Metzner B; Maschmeyer G; Kanz L; Schmidt C; Delarue R; Brousse N; Klapper W; Macintyre E; Delfau-Larue MH; Pott C; Hiddemann W; Unterhalt M; Dreyling M; Lancet; 2016 Aug; 388(10044):565-75. PubMed ID: 27313086 [TBL] [Abstract][Full Text] [Related]
18. Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial. Zoellner AK; Unterhalt M; Stilgenbauer S; Hübel K; Thieblemont C; Metzner B; Topp M; Truemper L; Schmidt C; Bouabdallah K; Krauter J; Lenz G; Dürig J; Vergote V; Schäfer-Eckart K; André M; Kluin-Nelemans HC; van Hoof A; Klapper W; Hiddemann W; Dreyling M; Hoster E; Lancet Haematol; 2021 Sep; 8(9):e648-e657. PubMed ID: 34450102 [TBL] [Abstract][Full Text] [Related]
19. Orbital MALT Lymphoma after Autologous Stem Cell Transplantation for Follicular Lymphoma as Relapse of Diffuse Large B-Cell Lymphoma. Matsuo T; Tanaka T; Fujii N J Clin Exp Hematop; 2017; 56(3):170-175. PubMed ID: 28331132 [TBL] [Abstract][Full Text] [Related]
20. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]